Global expansion EvaClean is actively expanding in Europe through EU Ltd partnerships, with recent deployments across Greece, Cyprus, Romania, Germany, France, Austria, Italy, Ireland, the UK, and the Middle East, signaling multi-country sales opportunities for regional distributors, resellers, and service integrators.

Healthcare focus The solution targets healthcare settings with proven biofilm and surface disinfection capabilities, offering a pathway to cross-sell into hospitals, clinics, long-term care facilities, and emergency response teams seeking compliant, repeatable infection prevention.

Disinfectant portfolio PurOne and PurTab disinfectants with NaDCC chemistry have EPA List-N and COVID-19 fighting product status, plus first EPA-registered biofilm-killing chemistry, presenting sales angles to facilities prioritizing high-efficacy, regulator-recognized products.

Electrostatic leadership Protexus electrostatic sprayers and associated workflow improvements reduce human error and operational costs, offering upsell opportunities to service providers, contractors, and educational facilities seeking scalable, efficient cleaning programs.

Strategic partnerships Active collaborations with distributors and end-user educators (The Infection Prevention Strategy, Microsplitting, Navy partnerships) indicate a channel-friendly model; leverage these relationships to expand into new markets, fleets, and multi-site deployments.